Article · 17 Oct 2026
OtherPublished 22 Dec 2006
Pharmacotherapy for Severe, Disabling, Subjective, Idiopathic Tinnitus: 2005-2006
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
We present a tinnitus-targeted therapy (TTT), a combined treatment of medication and instrumentation focusing on pharmacotherapy [1,2]. It embodies ongoing clinical experience (since 1977) in an excess of 8,500 patients with subjective idiopathic tinnitus of the severe disabling type (SIT). All have visited the Tinnitus Clinic of the Downstate Medical Center at the State University of New York (DMC/SUNY) and the Martha Entenmann Tinnitus Research Center, Inc. [1,2]. Since 1989, as a result of our evolving experience with single-photon emission computed tomography (SPECT) of brain, we have defined tinnitus as a sensory disorder of auditory perception exhibiting an aberrant auditory signal produced by interference in the excitatory-inhibitory process or processes involved in neurotransmission [1,2]. This definition is considered to be dynamic: It embodies the integration of clinical observations and advances reported from neuroscience and nuclear medicine. These investigations have sought to identify an underlying mechanism of tinnitus production and have assisted in the establishment of the medical significance of tinnitus [1–3]. In general, the goal of tinnitus therapy in 2005–2006 is to attempt to provide tinnitus relief for all clinical types of subjective idiopathic tinnitus (SIT). Although no cure for SIT exists currently, available protocols for diagnosis and treatment increase the efficacy of therapeutic modalities for attempting tinnitus relief [1,2]. The strategies of TTT are based on the clinical translation of fundamentals of sensory physiology, extrapolation of underlying neurochemistry from nuclear medicine imaging results with SPECT in SIT patients, hypotheses of mechanisms of tinnitus production, and the innovative application of drug therapies designed for indications other than tinnitus [1,2]. Such strategies have contributed to the development of a new discipline, tinnitology, an integrated multidiscipline of basic science, neuroscience, and clinical medicine attempting to understand an aberrant auditory phenomenon, unrelated to an external source of sound, and how it becomes transformed into one of affect. The goal of increasing accuracy of the SIT diagnosis is the impetus for increased efficacy of therapeutic modalities recommended for tinnitus relief.
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in The International Tinnitus Journal.
Article · 12 Oct 2026
Middle Ear Disease, Eustachian Tube Dysfunction and Hearing Outcomes in Children with Cleft Palate Living in Different Environmental Zones of the Aral Sea Region: A Comparative Observational Study
Article · 9 Oct 2026
Integrated Clinical, Endoscopic, and CBCT Phenotyping of Sinonasal Disease: Diagnostic and Audiological Implications
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalThe International Tinnitus Journal
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Abraham Shulman”
- BylineArticles whose byline prints “Barbara Goldstein”